Disparities in access to novel infusion treatment for Alzheimer’s disease revealed The adoption of Lecanemab, a new infusion treatment for Alzheimer’s disease (AD), has been disproportionately higher in patients who are…
Benefits and risks of popular weight-loss drugs revealed Demand for weight loss medications sold under brand names such as Ozempic and Wegovy continues to rise, with a recent…
